Skip to main content
. 2023 Aug 17;12(8):1626. doi: 10.3390/antiox12081626

Table 1.

Characteristics at screening for all enrolled men in the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Reproduced with permission from Table 1 of Steiner, Antioxidants 2020.

Data Are Presented as the Number (%) or Median (Interquartile Range).
Antioxidants (n = 85) Placebo (n = 86)
Age (years) 34.0 34.0
(30.0, 37.0) (30.0, 38.0)
Body mass index (kg/m2) 27.8 27.6
(24.2, 31.7) (24.4, 31.0)
n = 82
Ethnicity
  Hispanic or Latino 7 (8.2) 5 (5.8)
  Non-Hispanic 72 (84.7) 78 (90.7)
  Unknown 6 (7.1) 3 (3.5)
Race
  White 63 (74.1) 69 (80.2)
  Black 6 (7.1) 7 (8.1)
  Asian 7 (8.2) 2 (2.3)
  American Indian or Alaska Native 1 (12) 1 (12)
  Unknown 8 (9.4) 5 (5.8)
  Mixed Race 0 (0) 2 (2.3)
Abnormal semen parameters
  Single abnormal parameter
  Sperm concentration ≤ 15 million/mL 4 (4.7) 5 (5.8)
  Total motility ≤ 40% 9 (10.6) 10 (11.6)
  Normal morphology # ≤ 4% 33 (38.8) 29 (33.7)
>1 abnormal parameters 39 (45.9) 42 (48.8)
Fathered a prior pregnancy ^
  Yes 25 (29.4) 38 (44.2)
  No 60 (70.6) 48 (55.8)
Prior infertility treatment and/or surgery
  Yes 25 (29.4) 24 (27.9)
  No 60 (70.6) 62 (72.1)
Duration of infertility (months) 24.0 24.0
(18.0, 48.0) (15.0, 36.0)
n = 81 n = 83
History of smoking
  Never 54 (63.5) 47 (54.7)
  Current 8 (9.4) 11 (12.8)
  Former 23 (27.1) 28 (32.6)
History of alcohol use
  Never 6 (7.1) 4 (4.7)
  Current (in the past year) 72 (84.7) 81 (94.2)
 Former (not in the past year) 7 (8.2) 1 (12)

# WHO 5th criteria. ^ p < 0.05, Wilcoxon’s rank-sum test was used for the continuous variables, and Chi-square or Fisher’s exact test was used for categorical variables. Wilcoxon’s rank-sum test was used to test the distributional difference, instead of mean or median of the two groups.